The Latest Breaking News from Pfizer

Even as the war in Ukraine has prompted an exodus of international companies — from fast-food chains and oil producers to luxury retailers — from Russia, U.S. and global drug companies said they would continue manufacturing and selling their products there.

Coalition backbencher George Christensen took to Facebook this week to claim the government has suddenly stopped reporting vaccinated death statistics. Is that correct?

Pfizer Inc (NYSE: PFE) has initiated a Phase 2/3 EPIC-PEDS trial to evaluate Paxlovid (nirmatrelvir and ritonavir tablets) 

Here's a roundup of top developments in the biotech space over the last 24 hours.

‘Jared didn’t budge. In his mind, America was coming first no matter what,’ Albert Bourla writes

More research is needed, but likely omicron is to blame and not an overly low dosage for children

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 27 strange trades.

About 100,000 doses of Pfizer's COVID-19 vaccine are at risk of being destroyed by the end of this month due to slow uptake by citizens, South African health authorities said on Friday.

Pfizer Inc (NYSE:PFE) is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries in 2022, reports Reuters citing an official with the Global Fund. The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed at least that many…